NanoVibronix, Inc. - SIC # 3850 -

Ticker Exchange SIC # Website Latest Ticker
NAOV Nasdaq 3850 www.nanovibronix.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for NanoVibronix, Inc.

NanoVibronix Inc. (NAOV): 2025 Product Pipeline and Strategy Analysis Report - Oct 21st, 2025 10:09 am
NanoVibronix Launches "Oscar" Training Aid to Accelerate ENvue Adoption and Unlock New Revenue Opportunities - Sep 18th, 2025 6:00 am
NanoVibronix Announces Pricing of $2.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - Sep 16th, 2025 1:57 pm
NanoVibronix Announces Grant of New U.S. Patent Further Expanding ENvue Medical’s Intellectual Property Portfolio - Sep 15th, 2025 6:00 am
NanoVibronix Announces U.S. Patent Granted to ENvue Medical for Real-Time Imaging Overlay in Navigation Technology - Sep 4th, 2025 6:00 am
NanoVibronix Announces Reverse Stock Split - Aug 8th, 2025 7:00 am
NanoVibronix Announces Financing of up to $50 Million Private Placement of Preferred Stock - Jul 18th, 2025 7:00 am
NanoVibronix Announces ENvue Drive – First Intelligent Robotic Platform in Development for Bedside Feeding Tube and Vascular Line Navigation - Jun 26th, 2025 6:00 am
NanoVibronix’s ENvue Medical Division Announces Agreement with New York Medical Center to Implement ENvue™ Navigation Systems for Enteral Feeding Tube Placement - Jun 24th, 2025 6:00 am
ENvue Medical Granted U.S. Patent for Pediatric Feeding Tube Guidance System - Jun 11th, 2025 6:00 am
NanoVibronix Announces CEO Transition - Jun 4th, 2025 6:38 am
Major Louisiana Hospital Selects ENvue System for Feeding Tube Procedures - May 28th, 2025 6:00 am
NanoVibronix Announces Closing of $10 Million Public Offering of Preferred Stock and Warrants - May 16th, 2025 2:30 pm
NanoVibronix Announces Pricing of $10 Million Public Offering of Preferred Stock and Warrants - May 15th, 2025 7:00 am
NanoVibronix Announces Results from UroShield™ Case Series - May 12th, 2025 6:50 am
NanoVibronix Regains Nasdaq Compliance - Apr 11th, 2025 6:00 am
NanoVibronix Announces Renewal and Expansion of Distribution Agreement with Dukehill Healthcare Pty Ltd in Australia - Apr 1st, 2025 6:00 am
Why Nanovibronix Inc. (NAOV) Surged On Thursday? - Mar 21st, 2025 4:36 am
Successful Independent Study of the NanoVibronix UroShield® Device Published in the Australian and New Zealand Continence Journal - Mar 14th, 2025 6:00 am
NanoVibronix, Inc. Announces Acquisition of ENvue Medical Holdings, Corp. - Feb 14th, 2025 7:43 am